Implicit Decision-Making in the Treatment of Invisible Disease

People with early-stage breast cancer are given chemotherapy to reduce the risk of subsequent recurrence and death. Full doses are required for full benefit, yet many patients receive reduced doses of chemotherapy. Implicit decision-making on the part of physicians may account for dose reductions in many cases. This talk will describe the systematic under dosing of chemotherapy in black women, poor women, and obese women and present possible explanations for dose reductions as well as the implications of dose reductions in populations.

About the Speaker

Jennifer J. Griggs, MD, MPH

Jennifer Griggs, MD, MPH, is Professor of Medicine in the Division of Hematology/Oncology and Professor, Department of Health Management & Policy. A medical oncologist with a practice focused on the care of women with breast cancer, Dr. Grigg's research program addresses the quality of cancer care, optimal cancer care in obese patients, and patient-physician communication and decision-making.